Sentences with phrase «in tumor surgery»

Not exact matches

In January 2013, The Hartford announced that McGee had surgery for the removal of a brain tumor found during a routine checkup, and that he was cancer - free.

Plus, offensive line coach Geoff Dartt underwent brain surgery to remove two tumors in the middle of the season.

After John's diagnosis, when Isabella was in third grade, the family relocated from North Carolina to Michigan, then later, on to New York and Minnesota as John underwent surgeries to remove tumors, implant pain pumps and reconstruct parts of his skull.

A woman with previous breast surgery can get mastitis (infection of the breast tissues), galactocele formation (a milk filled tumor in your breast) and even galactorrhea (lactation that occurs without the occurrence of pregnancy or childbirth).

She died Wednesday, Feb. 7, around 6 p.m., from complications following surgery to remove several tumors in her reproductive tract.

When Daddy had emergency surgery on a cancerous tumor in his colon, the doctors told us in the post-op meeting

Besides the fact that this was a celebration of my dad, my hero and one of the most amazingly humble men on the planet, it was also a profound event because little did we know that in just 4 short months, Daddy would be undergoing emergency surgery on a cancerous tumor in his colon.

Republicans with exploratory committees include Danbury Mayor Mark Boughton, whose $ 33,790 in the third quarter brought his total to $ 195,941 (Boughton underwent surgery to remove a brain tumor during the quarter); State Sen. Toni Boucher of Wilton ($ 43,336 third quarter, $ 58,890 total) and Norwalk's Steve Obsitnik, who raised $ 63,696 in the third quarter and $ 265,363 to date.

Down but not out, NY1 anchor Roma Torre put on a brave face Thursday after undergoing surgery to remove a malignant tumor at Memorial Sloan Kettering Cancer Center in Manhattan...

Aside from the feat of answering the longstanding question of how the lymph system arises, understanding how it forms and develops can provide important insights into disease, from metastasis to the abnormal accumulation of lymph fluids, particularly in the wake of surgery to remove cancerous tumors.

Understanding how margin length decreases from surgery to pathology — because of how the removed tissue shrinks and tumor cells invade surrounding tissues — can lead to better surgical margin planning and in turn a better prognosis, said corresponding author Milan Milovancev, a board - certified veterinary surgeon at OSU's College of Veterinary Medicine.

If the tumor that Jobs had removed in 2004 had begun to break down prior to the surgery, White says, the tumor's dead cells could have released protease and lipase enzymes that may have damaged beta cells in the pancreas, which produce insulin.

A raft of studies in laboratory animals, molecular models and cancer patients suggest that pain drugs given during and after cancer surgery stimulate the growth and spread of certain tumors.

«We provide a framework for incorporating tumor imaging features and renal function into treatment selection, which may help to inform physicians regarding the appropriateness of surgery in patients with CKD,» Kang said.

So far, researchers with the Allen Institute for Brain Science in Seattle have described the intricate shapes and electrical properties of about 100 nerve cells, or neurons, taken from the brains of 36 patients as they underwent surgery for conditions such as brain tumors or epilepsy.

«Targeted radiosurgery better than whole - brain radiation for treating brain tumors: Study shows effectiveness of radiosurgery in controlling spread of brain cancer after surgery.»

«We know that 70 - 75 percent of glioblastoma patients undergo surgery for tumor debulking, and we have previously shown that MSCs encapsulated in biocompatible gels can be used as therapeutic agents in a mouse model that mimics this debulking,» he continued.

The finding has already garnered attention from researchers across Canada, including internationally recognized brain tumor scientist and neurosurgeon Dr. James Rutka, Professor and Chair, Department of Surgery, University of Toronto and Dr. Rolando Del Maestro, William Feindel Professor Emeritus in Neuro - Oncology, McGill University.

In other words, regardless of surgery timing, patients who require higher risk procedures, such as a major liver resection due to the presence of larger or multiple metastatic tumors or high - risk colorectal resections, have poorer outcomes than those who underwent more minor surgery.

Produced by a technique called fiber tractography, the image helped doctors at Sherbrooke University Hospital Center in Quebec avoid cutting vital circuitry during brain surgery: The reddest nerve fibers were those most likely to be severed by incisions to remove the tumor.

As reported at the American Society of Clinical Oncology meeting in June, the vaccine, together with radiation and chemotherapy, prevented the brain tumor from reemerging after surgery for 12 months as compared with the typical six to seven months with no vaccine.

Says Bachleitner - Hofmann: «Especially in specialist centres, robotic surgery should be the standard procedure for removing a colorectal tumor, since it has clear advantages over the other methods, particularly for low - lying rectal cancers.

Patients with uveal melanoma receive surgery to remove the tumor — and in some advanced cases, the entire eye — as well as radiation therapy or chemotherapy.

Subsequent surgery on vaccinated patients has shown that the T cells are finding and killing tumor cells in the brain, but not enough of them.

The new «tumor in a dish» method begins by taking the cancerous tissue removed during surgery or biopsy, cutting it up into small pieces and putting them in a special collagen gel that maintains them as «organoids» that retain the three - dimensional structure of the original tumor and include supporting cells from the tumor's environment.

«However, IL6 - secreting tumors could be laying the groundwork for metastasis much earlier than surgery occurs in a patient,» he said.

«Currently, approximately 1 in 5 women who undergo breast - conserving surgery, also known as lumpectomy, require repeat surgery due to inadequate excision of the tumor during the initial surgical procedure,» explains Arnie D. Purushotham, MD, professor at King's College London, UK.

F -18-FDG CLI is, therefore, a promising, low - risk technique for intraoperative assessment of tumor margins in breast - conserving surgery.

Neurosurgeon Mitchel Berger at U.C. San Francisco conducts hands - on «brain mapping» of language functions in advance of surgery to remove tumors.

«Pancreatic cancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Langone.

The first long - term study of a pioneering endoscopic laser treatment for early vocal - cord cancer, developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients» tumors while avoiding the damage to vocal quality caused by radiotherapy or by conventional laser or cold - instrument surgery.

«In our Phase I / II clinical studies with PDT alone, tumor destruction was achieved in all cases, and we've seen at least one case where PDT alone induced enough tumor shrinkage to enable follow - up surgerIn our Phase I / II clinical studies with PDT alone, tumor destruction was achieved in all cases, and we've seen at least one case where PDT alone induced enough tumor shrinkage to enable follow - up surgerin all cases, and we've seen at least one case where PDT alone induced enough tumor shrinkage to enable follow - up surgery.

Although surgical excision of tumors remains the standard of care for renal tumors that have not yet spread (localized), the risk of complications in elderly or ill patients may outweigh the benefits of surgery.

In patients likely to have surgery, close, active monitoring of small renal tumors confined to the kidneys is associated with low rates of tumor growth or death, according to a study by a researcher at the Icahn School of Medicine at Mount Sinai published in the September issue of The Journal of UrologIn patients likely to have surgery, close, active monitoring of small renal tumors confined to the kidneys is associated with low rates of tumor growth or death, according to a study by a researcher at the Icahn School of Medicine at Mount Sinai published in the September issue of The Journal of Urologin the September issue of The Journal of Urology.

In cases which are likely to result in surgery, it is important that urologists understand the natural history of renal tumorIn cases which are likely to result in surgery, it is important that urologists understand the natural history of renal tumorin surgery, it is important that urologists understand the natural history of renal tumors.

Unfortunately, approximately 85 percent of cancer patients are ineligible for surgery at the time of diagnosis, either because the tumor is entwined in critical vasculature or the disease has progressed too far.

«These findings raise the possibility that by determining the gene expression profile of a patient's tumor, physicians may be able to identify aggressive disease at the outset of diagnosis and start treatment earlier,» said Sungyong You, PhD, an instructor in the Cedars - Sinai Department of Surgery and the first author of the study.

The systemic response to surgery triggers the outgrowth of distant immune - controlled tumors in mouse models of dormancy

The study suggests that actively monitoring renal tumors in some patients may prove a safer option than immediate surgery.

Meng and Nel also collaborated with Dr. Timothy Donahue, chief of gastrointestinal and pancreatic surgery and a Jonsson Comprehensive Cancer Center member, to demonstrate that treatment with the iRGD peptide can enhance tumor cell killing for patient - derived pancreatic cancers, growing subcutaneously in a mouse model.

Within the first two weeks of infusion, a detectable number of CART - EGFRvIII cells trafficked to the tumors, with signs of activation in the four patients who had «early surgery,» the researchers reported.

Storm, who performs surgery on children with brain tumors, added that, «Better understanding of tumor characteristics, as we found in this research, will help guide our surgical planning and clinical decisions for patients with PLGGs in this current era of target - centric clinical trials and personalized medicine.»

As detailed in a recent study by Dr. Margulis in The Journal of Urology, «Patients with the disease who undergo surgery have a mortality rate that can be as high as 10 percent, depending on the location of the tumor and its growth into the venous system.

«While IVC tumor thrombus occurs in only 4 - 10 % of all patients with otherwise organ - confined kidney cancer, surgery is the only cure.

If we validate this study in similar, but larger groups of patients, we can develop a test based for CFS breaks; the results would allow us to place patients in one of two categories: those whose tumors do not have CFS breaks and who would likely do well with local treatment alone (e.g. radiotherapy or surgery); and, those patients whose tumors do have CFS breaks and would need a more complex treatment protocol, in addition to RT or surgery, to combat distant spread.»

A newly devised tumor - specific fluorescent agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery, reports Alexander L. Vahrmeijer MD, PhD, head of the Image - guided Surgery group in the Department of Surgery at Leiden University Medical Center in the Nethesurgery, reports Alexander L. Vahrmeijer MD, PhD, head of the Image - guided Surgery group in the Department of Surgery at Leiden University Medical Center in the NetheSurgery group in the Department of Surgery at Leiden University Medical Center in the NetheSurgery at Leiden University Medical Center in the Netherlands.

If the tumor is large or there's obvious evidence that the cancer is in the lymph nodes, you take them out,» said author Julie Ann Sosa, M.D., chief of endocrine surgery and leader of the endocrine neoplasia diseases group at the Duke Clinical Research Institute and the Duke Cancer Institute.

The proportion of failed breast conservation surgery in these hospitals ranged from 3 - 32 %, while the proportion of mastectomies for small tumors ranged from 0 - 60 %.

A new study by UCLA scientists has found that women diagnosed with breast cancer and treated with a one - week regimen of partial breast radiation after the surgical removal of the tumor, or lumpectomy, saw no increase in cancer recurrence or difference in cosmetic outcomes compared to women who received radiation of the entire breast for a period of up to six weeks after surgery.

«Level III IVC tumor thrombectomy for renal cancer is one of the most challenging open urologic oncologic surgeries,» explained Inderbir S. Gill, MD, of the USC Institute of Urology, part of Keck Medicine of USC in Los Angeles, CA.